MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,526,534 | +172.1% | 1,825,678 | +125.7% | 0.25% | +143.6% |
| Q2 2023 | $29,222,667 | +207.1% | 808,820 | +216.0% | 0.10% | +197.1% |
| Q1 2023 | $9,516,593 | +123604.6% | 255,960 | +50.8% | 0.03% | +21.4% |
| Q4 2022 | $7,693 | -99.9% | 169,785 | -12.2% | 0.03% | -46.2% |
| Q3 2022 | $13,509,000 | -76.4% | 193,428 | -77.3% | 0.05% | -75.5% |
| Q2 2022 | $57,191,000 | +1202.2% | 851,950 | +1494.8% | 0.21% | +1666.7% |
| Q1 2022 | $4,392,000 | -67.5% | 53,422 | -42.0% | 0.01% | -69.2% |
| Q4 2021 | $13,519,000 | -78.9% | 92,160 | -74.6% | 0.04% | -81.0% |
| Q3 2021 | $64,148,000 | +9.2% | 362,600 | -0.3% | 0.20% | +3.0% |
| Q2 2021 | $58,726,000 | +17.6% | 363,559 | +24.7% | 0.20% | -2.0% |
| Q1 2021 | $49,940,000 | +393.8% | 291,538 | +533.1% | 0.20% | +361.4% |
| Q4 2020 | $10,114,000 | -52.7% | 46,050 | -64.2% | 0.04% | -63.3% |
| Q3 2020 | $21,387,000 | +84.8% | 128,800 | +27.1% | 0.12% | +62.2% |
| Q2 2020 | $11,574,000 | – | 101,374 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |